Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation??

By Caserta Donatella   Lisi Franco   Marci Roberto   Ciardo Francesca   Fazi Alessandra   Lisi Roberta   Moscarini Massimo  

Gynecological Endocrinology, Vol. 27, Iss. 11, 2011-11 ,pp. : 862-866

Informa Healthcare

Access to resources Recommend Favorite

Role of ultrasonographic markers of ovarian reserve in prediction of IVF and ICSI outcome

By Shaban Mona Mohamed   Abdel Moety Ghada Abdel Fattah  

Gynecological Endocrinology, Vol. 30, Iss. 4, 2014-04 ,pp. : 290-293

Informa Healthcare

Access to resources Recommend Favorite

Intravenous albumin does not prevent moderate‐severe ovarian hyperstimulation syndrome in high‐risk IVF patients: a randomized controlled study

By Bellver José   Muñoz Elkin A.   Ballesteros Agustín   Soares Sérgio Reis   Bosch Ernesto   Simón Carlos   Pellicer Antonio   Remohí José  

Human Reproduction, Vol. 18, Iss. 11, 2003-11 ,pp. : 2283-2288

Oxford University Press

Access to resources Recommend Favorite

Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve

By Hendriks D.J.  

Human Reproduction, Vol. 20, Iss. 1, 2005-01 ,pp. : 163-169

Oxford University Press

Access to resources Recommend Favorite

Infertility. Low-dose dexamethasone augments the ovarian response to exogenous gonadotrophins leading to a reduction in cycle cancellation rate in a standard IVF programme

By Keay S.D.  

Human Reproduction, Vol. 16, Iss. 9, 2001-09 ,pp. : 1861-1865

Oxford University Press

Access to resources Recommend Favorite